BRCA1 and neoplasm: Although we have determined that CNV analysis utilizing ev- and cfDNA is not favorable, we have actually detected the same BRCA1 CNVs in tumor- and evDNA, including the heterozygous deletion, in four out of nine patients and none in cfDNA.